UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

Nature communications, 2020-01, Vol.11 (1), p.246-246, Article 246

2020

Volltextzugriff (PDF)

The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study

Translational psychiatry, 2021-07, Vol.11 (1), p.393-393, Article 393

2021

Volltextzugriff (PDF)

Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease[S]

Journal of lipid research, 2013-05, Vol.54 (5), p.1346-1359

2013

Volltextzugriff (PDF)

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [ 11 C]PHNO PET

Neuropsychopharmacology (New York, N.Y.), 2022-06, Vol.47 (7), p.1405-1412

2022

Volltextzugriff (PDF)

Test–retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brain

Journal of cerebral blood flow and metabolism, 2021-04, Vol.41 (4), p.771-779

2021

Volltextzugriff (PDF)

Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J

The Journal of nuclear medicine (1978), 2020-01, Vol.61 (1), p.96-103

2020

Volltextzugriff (PDF)

Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study

EJNMMI research, 2024-04, Vol.14 (1), p.41-41, Article 41

2024

Volltextzugriff (PDF)

Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease

Movement disorders, 2020-08, Vol.35 (8), p.1416-1427

2020

Volltextzugriff (PDF)

Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease

Science translational medicine, 2022-08, Vol.14 (658), p.eabk1051

2022

Volltextzugriff (PDF)

Test-retest variability and reference region-based quantification of 18 F-BCPP-EF for imaging mitochondrial complex I in the human brain

Journal of cerebral blood flow and metabolism, 2021-04, Vol.41 (4), p.771-779

2021

Volltextzugriff (PDF)

Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A

Biological psychiatry (1969), 2024-04, Vol.95 (7), p.639-646

2024

Volltextzugriff (PDF)

Imaging of Mitochondrial Complex 1 with 18F-BCPP-EF in the Healthy Human Brain

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1709

2018

Volltextzugriff (PDF)

Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge

Journal of cerebral blood flow and metabolism, 2021-10, Vol.41 (10), p.2778-2796

2021

Volltextzugriff (PDF)

O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS

Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S28-S28

2020

Volltextzugriff (PDF)

Synaptic PET imaging using [11C]UCB‐J in frontotemporal dementia

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

2021

Volltextzugriff (PDF)

Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18 F-BCPP-EF, 11 C-SA-4503, and 11 C-UCB-J

Journal of Nuclear Medicine, 2020-01, Vol.61 (1), p.96-103

2020

Volltextzugriff (PDF)

The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study

Imaging neuroscience (Cambridge, Mass.), 2024-06, Vol.2, p.1-16

2024

Volltextzugriff (PDF)

P2‐366: QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER'S DISEASE USING [18F]BCPP‐EF, [11C]SA4503 AND [11C]UCB‐J PET IMAGING

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_14), p.P740-P741

2019

Volltextzugriff (PDF)

QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER’S DISEASE USING [18F]BCPP-EF, [11C]SA4503 AND [11C]UCB-J PET IMAGING

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P740-P741

2019

Volltextzugriff (PDF)

PET-MR Attenuation Correction in Dynamic Brain PET Using [11C]Cimbi-36: A Direct Comparison With PET-CT

IEEE transactions on radiation and plasma medical sciences, 2018-09, Vol.2 (5), p.483-489

2018

Volltextzugriff (PDF)

Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis

The EMBO journal, 2011-11, Vol.30 (21), p.4337-4339

2011

Volltextzugriff (PDF)

Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis: LD meets a mitochondrial protein to regulate adipocyte lipolysis

The EMBO journal, 2011-11, Vol.30 (21), p.4337-4339

2011

Volltextzugriff (PDF)

Neonatal outcome following new assisted reproductive technology regulations in Turkey - a nationwide multicenter point prevalence study

The journal of maternal-fetal & neonatal medicine, 2015-01, Vol.28 (2), p.204-209

2015

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study

Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease[S]

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [ 11 C]PHNO PET

Test–retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brain

Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J

Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study

Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease

Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease

Test-retest variability and reference region-based quantification of 18 F-BCPP-EF for imaging mitochondrial complex I in the human brain

Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A

Imaging of Mitochondrial Complex 1 with 18F-BCPP-EF in the Healthy Human Brain

Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge

O11.3. SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS

Synaptic PET imaging using [11C]UCB‐J in frontotemporal dementia

Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18 F-BCPP-EF, 11 C-SA-4503, and 11 C-UCB-J

The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study

P2‐366: QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER'S DISEASE USING [18F]BCPP‐EF, [11C]SA4503 AND [11C]UCB‐J PET IMAGING

QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER’S DISEASE USING [18F]BCPP-EF, [11C]SA4503 AND [11C]UCB-J PET IMAGING

PET-MR Attenuation Correction in Dynamic Brain PET Using [11C]Cimbi-36: A Direct Comparison With PET-CT

Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis

Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis: LD meets a mitochondrial protein to regulate adipocyte lipolysis

Neonatal outcome following new assisted reproductive technology regulations in Turkey - a nationwide multicenter point prevalence study

Suchergebnisse filtern